retatrutide phase 2 nejm 2023 obesity trial jastreboff Another Promising Medication (Retatrutide) for Retatrutide for Obesity: Phase 2

It represents the closest competitor to Retatrutide in terms of efficacy and is currently FDA-approved

Practical Pain Management

Support depth differs

Never discontinue Ozempic without medical supervision, as abrupt cessation may lead to deterioration in glycaemic control

But unlike the pharma giants that produce the originals, these virtual clinics and specialty pharmacies are offering versions of semaglutide and tirzepatide for weight loss that are taken by mouth

When to seek help red flags: Contact your GP or trial clinician promptly if you experience persistent or worsening nausea and vomiting, are unable to keep fluids down for more than 24 hours, or notice significant unintentional weight loss or difficulty maintaining adequate nutrition